S2P fundamentals
SIMCERE PHARMAC. GRP LTD financial statements, including revenue, expenses, profit, and loss
The total revenue of S2P for the last semiannual is 404.58 M EUR, and it's 9.49% lower compared to the previous semiannual. The net income of H2 23 is -195.48 M EUR.
0.00
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: EUR
TTM